TSS
MED icon

Two Sigma Securities’s Medifast MED Stock Holding History

Two Sigma Securities’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,200
Closed -$550K – 3335
2024
Q2 		$550K Buy
+25,200
New +$672K 0.01% 1471
2024
Q1 		– Sell
-4,500
Closed -$302K – 3358
2023
Q4 		$302K Sell
4,500
-1,700
-27% -$118K ﹤0.01% 1997
2023
Q3 		$464K Sell
6,200
-3,100
-33% -$275K ﹤0.01% 1589
2023
Q2 		$857K Buy
9,300
+6,100
+191% +$543K 0.01% 1065
2023
Q1 		$332K Sell
3,200
-2,000
-38% -$222K 0.01% 1599
2022
Q4 		$600K Sell
5,200
-4,200
-45% -$489K 0.02% 965
2022
Q3 		$1.02M Buy
9,400
+7,400
+370% +$1.06M 0.03% 627
2022
Q2 		$361K Buy
+2,000
New +$358K 0.01% 1147

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Securities's MED Position: Q1 2024 in Review

Two Sigma Securities sold out of Medifast (MED) in Q1 2024, closing a stake of 3,673 shares — an estimated $247K sold.

Two Sigma Securities first reported a position in MED in Q1 2022 and held it in 4 quarters. The position peaked at $359K in Q4 2022. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Two Sigma Securities reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 3,673 Medifast shares in Q1 2024, an estimated $247K.
  • Two Sigma Securities first reported a position in Medifast in Q1 2022 and held it in 4 quarters.
  • Two Sigma Securities's Medifast position peaked at $359K in Q4 2022.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.